Simvastatin-induced	simvastatin-induced	O	O	O	O
bilateral	bilateral	O	O	O	O
leg	leg	O	O	O	O
compartment	compartment	O	O	OTHERS	I
syndrome	syndrome	O	O	OTHERS	I
and	and	O	O	O	O
myonecrosis	myonecrosis	O	O	OTHERS	I
associated	associated	O	O	O	O
with	with	O	O	O	O
hypothyroidism	hypothyroidism	O	DISEASE	OTHERS	I
.	.	O	O	O	O

A	a	O	O	O	O
54-year-old	54-year-old	O	O	O	O
hypothyroid	hypothyroid	O	DISEASE	OTHERS	I
male	male	O	O	O	O
taking	taking	O	O	O	O
thyroxine	thyroxine	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
simvastatin	simvastatin	CHEMICALS	O	OTHERS	I
presented	presented	O	O	O	O
with	with	O	O	O	O
bilateral	bilateral	O	O	O	O
leg	leg	O	O	O	O
compartment	compartment	O	O	OTHERS	I
syndrome	syndrome	O	O	OTHERS	I
and	and	O	O	O	O
myonecrosis	myonecrosis	O	O	OTHERS	I
.	.	O	O	O	O

Urgent	urgent	O	O	O	O
fasciotomies	fasciotomies	O	O	O	O
were	were	O	O	O	O
performed	performed	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
patient	patient	O	O	O	O
made	made	O	O	O	O
an	an	O	O	O	O
uneventful	uneventful	O	O	O	O
recovery	recovery	O	O	O	O
with	with	O	O	O	O
the	the	O	O	O	O
withdrawal	withdrawal	O	O	O	O
of	of	O	O	O	O
simvastatin	simvastatin	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

It	it	O	O	O	O
is	is	O	O	O	O
likely	likely	O	O	O	O
that	that	O	O	O	O
this	this	O	O	O	O
complication	complication	O	O	O	O
will	will	O	O	O	O
be	be	O	O	O	O
seen	seen	O	O	O	O
more	more	O	O	O	O
often	often	O	O	O	O
with	with	O	O	O	O
the	the	O	O	O	O
increased	increased	O	O	O	O
worldwide	worldwide	O	O	O	O
use	use	O	O	O	O
of	of	O	O	O	O
this	this	O	O	O	O
drug	drug	O	O	O	O
and	and	O	O	O	O
its	its	O	O	O	O
approval	approval	O	O	O	O
for	for	O	O	O	O
all	all	O	O	O	O
arteriopathic	arteriopathic	O	O	OTHERS	I
patients	patients	O	O	O	O
.	.	O	O	O	O

